Authors: Mavroudis, D Papadakis, E Veslemes, M Tsiafaki, X Stavrakakis, J Kouroussis, C Kakolyris, S Bania, E Jordanoglou, J Agelidou, M Vlachonicolis, J Georgoulias, V

Citation: D. Mavroudis et al., A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer, ANN ONCOL, 12(4), 2001, pp. 463-470

Authors: Georgoulias, V Papadakis, E Alexopoulos, A Tsiafaki, X Rapti, A Veslemes, M Palamidas, P Vlachonikolis, I

Citation: V. Georgoulias et al., Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial, LANCET, 357(9267), 2001, pp. 1478-1484

Authors: Mariatos, G Gorgoulis, VG Zacharatos, P Kotsinas, A Vogiatzi, T Rassidakis, G Foukas, P Liloglou, T Tiniakos, D Angelou, N Manolis, EN Veslemes, M Field, JK Kittas, C

Citation: G. Mariatos et al., Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: Relationship with tumor growth parameters and ploidy status, INT J CANC, 89(2), 2000, pp. 133-141

Authors: Polyzos, A Tsavaris, N Kosmas, C Petrikos, G Giannikos, L Kalahanis, N Papadopoulos, O Christodoulou, K Giannakopoulos, K Veslemes, M Katsilambros, N

Citation: A. Polyzos et al., Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide, J CHEMOTHER, 11(2), 1999, pp. 144-149

Authors: Gorgoulis, VG Zacharatos, P Kotsinas, A Liloglou, T Kyroudi, A Veslemes, M Rassidakis, A Halazonetis, TD Field, JK Kittas, C

Citation: Vg. Gorgoulis et al., Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas - Relationship with p53 and MDM2 protein expression, AM J PATH, 153(6), 1998, pp. 1749-1765